The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotlan, B.
Right arrow Articles by Glassy, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotlan, B.
Right arrow Articles by Glassy, M. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Breast Cancer
The Journal of Immunology, 2005, 175: 2278-2285.
Copyright © 2005 by The American Association of Immunologists

Novel Ganglioside Antigen Identified by B Cells in Human Medullary Breast Carcinomas: The Proof of Principle Concerning the Tumor-Infiltrating B Lymphocytes1

Beatrix Kotlan*,§, Peter Simsa*, Jean-Luc Teillaud{dagger}, Wolf Herman Fridman{dagger}, Jozsef Toth{ddagger}, Michael McKnight§ and Mark C. Glassy2,§,||

* National Medical Center/Institute of Haematology and Immunology, Budapest, Hungary; {dagger} Institut National de la Santé et de la Recherche Médicale Unité 255, Centre de Recherches Biomedicales des Cordeliers, Universite Pierre et Marie Curie, Paris, France; {ddagger} National Institute of Oncology, Budapest, Hungary; § Rajko Medenica Research Foundation, San Diego, CA 92121; Shantha West, San Diego, CA 92121; and || University of California, San Diego Mechanical and Aerospace Engineering Department, La Jolla, CA 92037

The potential tumor-recognizing capacity of B cells infiltrating human breast carcinoma is an important aspect of breast cancer biology. As an experimental system, we used human medullary breast carcinoma because of its heavy B lymphocytic infiltration paralleled to a relatively better prognosis. Ig-rearranged V region VH-JH, V{kappa}-J{kappa}, and V{lambda}-J{lambda} genes, amplified by RT-PCR of the infiltrating B cells, were cloned, sequenced, and subjected to a comparative DNA analysis. A combinatorial single-chain variable fragment Ab minilibrary was constructed out of randomly selected VH and V{kappa} clones and tested for binding activity. Our data analysis revealed that some of the VH-JH, V{kappa}-J{kappa}, and V{lambda}-J{lambda} region sequences were being assigned to clusters with oligoclonal predominance, while other characteristics of the Ab repertoire were defined also. A tumor-restricted binder clone could be selected out of the single-chain variable fragment {kappa} minilibrary tested against membrane fractions of primary breast tumor cells and tumor cell lines, the VH of which proved to be the overexpressed VH3-1 cluster. The specific binding was confirmed by FACS analysis with primary breast carcinoma cells and MDA-MB 231 cell line. ELISA and thin layer chromatography dot-blot experiments showed this target Ag to be a ganglioside D3 (GD3). Our results are a proof of principle about the capacity of B cells infiltrating breast carcinomas to reveal key cancer-related Ags, such as the GD3. GD3-specific Abs may influence tumor cell progression and could be used for further development of diagnostic and/or therapeutic purposes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. N. Willis, S. S. Mallozzi, S. J. Rodig, K. M. Cronk, S. L. McArdel, T. Caron, G. S. Pinkus, L. Lovato, K. L. Shampain, D. E. Anderson, et al.
The Microenvironment of Germ Cell Tumors Harbors a Prominent Antigen-Driven Humoral Response
J. Immunol., March 1, 2009; 182(5): 3310 - 3317.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Schmidt, D. Bohm, C. von Torne, E. Steiner, A. Puhl, H. Pilch, H.-A. Lehr, J. G. Hengstler, H. Kolbl, and M. Gehrmann
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
Cancer Res., July 1, 2008; 68(13): 5405 - 5413.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.